Stress myocardial perfusion rubidium-82 PET provides effective risk stratification in 6,037 patients, especially in women ≥ 55years, with symptoms of coronary artery disease.
Most recent articles
8th Thematic workshop in NANTES on june 18th 2013: “Which tools for tumor targeting?”
Tumor targeting is a central aspect of the Tumor Targeting & Radiotherapies network of the Cancéropôle Grand Ouest. This network brings together many teams of west of France including chemists, biologists, radiopharmacists, physicists, nuclear medicine physicians and oncologists.
The workshop will be an opportunity not only to present scientific advances in the field oftumor targeting, so they are (...)
Our new multilingual Web site, including ArronaxPlus, is now open.